Xin Lang Ke Ji·2025-11-24 11:57Core Insights - The flu season is currently at a peak, with significant increases in demand for flu medications reported by JD's medicine delivery platform [1] - The demand for antiviral drugs has surged dramatically, with specific products seeing exponential growth in sales [1] Group 1: Demand Surge - From November 17 to November 23, the sales of Oseltamivir increased by 4.5 times, and the sales of Sufentanil surged by 5 times [1] - The sales of flu test kits rose by 4.8 times, while cough and pain relief medications increased by over 3 times [1] - The overall transaction value for flu medications increased by 22 times year-on-year during the same period [1] Group 2: Specific Product Performance - Sufentanil and Kewai saw transaction values increase by over 40 times year-on-year, while Tamiflu's transaction value grew by 24 times [1] - Common cold and cough medication sales doubled year-on-year, with specific products like the Four Seasons Antiviral Mixture and Lianhua Qingwen capsules seeing sales increase by over 5 times [1] Group 3: Testing and Medical Services - The number of respiratory bacterial and viral testing orders increased by 66% week-on-week, with a positive detection rate rising to 68.2% [1] - The demand for home sampling services by professional nurses nearly doubled in the same period [1] - JD's online hospital reported a 51% week-on-week increase in consultations for fever-related symptoms, providing rapid professional support to users [1][2]